LITS
Lite Strategy, Inc.
NASDAQ: LITS · HEALTHCARE · BIOTECHNOLOGY
$1.25
-13.35% today
Updated 2026-06-05
Market cap
$25.47M
P/E ratio
—
P/S ratio
0.30x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$1 – $8
Volume
0.4M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.0
Profitability
D4.7
Valuation
C3/9
Piotroski F-Score
Weak
-25.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -25.48 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.52M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $40.70M | $48.82M | $65.30M | $0.00 | $0.00 |
| Net income | $-54.45M | $-31.84M | $17.78M | $-15.95M | $-23.69M |
| EPS | — | — | — | — | $-2.08 |
| Free cash flow | $-49.23M | $-52.52M | $-50.48M | $-20.84M | $-1.52M |
| Profit margin | -133.80% | -65.22% | 27.23% | — | — |
Peer comparison
Smart narrative
Lite Strategy, Inc. trades at $1.25. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -25.48, it sits in the distress.
Frequently asked questions
What is Lite Strategy, Inc.'s stock price?
Lite Strategy, Inc. (LITS) trades at $1.25, on a P/S of 0.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Lite Strategy, Inc. overvalued?
Lite Strategy, Inc. carries a Smart Value Score of 41/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Lite Strategy, Inc.'s Altman Z-Score is -25.48, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.30x
ROE-107.01%
Beta0.04
50D MA$1.13
200D MA$1.79
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—